Dr. Roxanna Namavar is a Board-Certified psychiatrist and fellow in the American Academy of Anti-Aging.

​

Along with her team, Dr. Namavar supervises due diligence in companies, both public and private, specializing in novel, scientifically-backed processes and devices for family offices. She oversees investments in healthcare and related hedge and private equity funds, along with direct investments. Dr. Namavar typically focuses on evaluating early and latter-stage companies and venture capital in the healthcare and biotech arena. Her current concentrations are wellness companies, brain health, psychedelics, and all-encompassing neuro-tech. 

​

Dr. Namavar maintains a practice that provides executive coaching for healthcare and cognitive optimization, working with HNWI and financial institutions.